API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. THER.PINK

Therasense Inc (THER PINK) stock market data APIs

$0.0001 0(0%) as of September 10, 2024
Price chart is built with Anychart

Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. In addition, the company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. The company was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies, Inc.is headquartered in Golden, Colorado.

Therasense Inc Financial Data Overview

0.0001
0.0001
-
0.0001
0.0001
0.0001-0.0023
615 K
6 151 M
635 K
20.16
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'THER',
Type: 'Common Stock',
Name: 'Therasense Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000R20SB1',
ISIN: NULL,
CUSIP: '883381105',
CIK: '1512717',
EmployerIdNumber: NULL,
FiscalYearEnd: 'September',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Therasense Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 635 K
  • EBITDA -7 507 841
  • Earnings Per Share 0
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Therasense Inc Earnings via APIs

  • Latest Release 2024-09-04
  • EPS/Forecast NaN

Get Therasense Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Therasense Inc latest news via APIs

Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4

Golden, Colorado & Nashville, Tennessee, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision oncology company with its exclusive commercial RPPA...
  • EXCHANGE COMMISSION
  • FDA-APPROVED DRUG
  • INC
  • OTC: THER
  • OTHER OTC:THER
  • PRESS RELEASES
  • SECURITIES
  • TECHNOLOGY
  • THERALINK TECHNOLOGIES

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board

Golden, Colorado, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision oncology company with its exclusive commercial RPPA (reverse phase protein...
  • INC
  • INOVA SCHAR CANCER INSTITUTE’S
  • INTERIM RESULTS
  • MOLECULAR TUMOR BOARD
  • OTHER OTC:THER
  • PRESS RELEASES
  • PROTEOMIC ANALYSIS
  • THERALINK TECHNOLOGIES
Do you have any questions?
support@eodhistoricaldata.com